Labang, Baby Boy .

HRN: 29-25-13  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
AMPICILLIN 250MG (VIAL)
06/28/2026
07/05/2026
IV
63mg
Q12
PSNB
Checking Initial Appropriateness 
06/28/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/28/2026
07/05/2026
IV
19mg
Q24
PSNB
Checking Initial Appropriateness 
07/05/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
07/05/2026
07/05/2026
IVT
12.5mg
Loading Dose
RDS; Neonatal Sepsis
Checking Initial Appropriateness 
07/05/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
07/05/2026
07/11/2026
IVT
6.2mg
Q8H
RDS; Neonatal Sepsis
Checking Initial Appropriateness 
07/11/2026
CEFOTAXIME 500MG (VIAL)
07/11/2026
07/18/2026
IV
60mg
Q12h
RDS, Neonatal Sepsis
Checking Initial Appropriateness 
07/14/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/14/2026
07/20/2026
IV
18mg
Q24
Neonatal Sepsis
Checking Final Appropriateness 
07/14/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/14/2026
07/14/2026
IV
80mg
Q8h
Neonatal Sepsis
Checking Final Appropriateness 
07/16/2026
CEFTRIAXONE 1G (VIAL)
07/16/2026
07/16/2026
IVT
120mg
Loading Dose
Neonatal Sepsis (Klebsiella Pneumoniae)
Checking Final Appropriateness 
07/16/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
07/16/2026
07/22/2026
IVT
5mg
Q24H
Neonatal Sepsis (Klebsiella Pneumoniae)
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: